Article Details
Retrieved on: 2018-01-14 05:11:15
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
<div><b>Benchmark Capital</b> Advisors who had been investing in Sarepta Therapeutics I Com for a number of months, seems to be bullish on the $3.98B market cap company. The stock increased 4.29% or $2.53 during the last trading session, reaching $61.52. About 2.22M shares traded or 23.78% up from the ...</div>
Article found on:
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here